The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis
Clinical trial NCT03026556 · COMPLETED
Trial details
- NCT number
- NCT03026556
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-29
- Primary completion
- 2017-08-23
- Enrollment
- 42534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.